Who
SVF Pauling (Cayman) Ltd
10% owner
Company insider
Files Form 4 as: 10% owner, Relay Therapeutics.
In numbers
- Trades disclosed
- 3
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $116.4M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 20 Jul 2020
- Last trade
- 25 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Aug 2026filed 28 Aug 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $116.4M6,000,000 at $19.40 | filing |
| 20 Jul 2020filed 21 Jul 2020 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —99,088,292 at $0.00 | filing |
| 20 Jul 2020filed 21 Jul 2020 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code C | —27,904,963 at $0.00 | filing |
News
Head-To-Head Comparison: Krystal Biotech (NASDAQ:KRYS) and Relay Therapeutics (NASDAQ:RLAY)RLAY · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name SVF Pauling (Cayman) Ltd; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.